A new Scripps Institution of Oceanography at UC San Diego-led study measured a melt rate that is 25 times higher than expected on one part of the Ross Ice Shelf. The study suggests that high, localized melt rates such as this one on Antarctica’s largest and most stable ice shelf are normal and keep Antarctica’s ice sheets in balance.
Researchers at University of California, San Diego School of Medicine and Samsara Sciences, Inc., a wholly-owned subsidiary of Organovo Holdings, Inc., have entered into an agreement focused on the development of techniques and methods for the isolation and characterization of liver cells that will help drive new research on liver biology, drug safety and efficacy, and the treatment of liver diseases.
Howard Feldman, MD, FRCP(C), a renowned Canadian neurologist noted for his original research in geriatric cognitive disorders and expertise in large-scale clinical trials, has been named the new director of the Alzheimer’s Disease Cooperative Study (ADCS) at University of California, San Diego, pending approval from the National Institute on Aging (NIA).
The movie premiere was still more than a week away, but Star Wars fever was already peaking at UC San Diego Dec. 9 during the campus’ semi-annual robotics competition. This year, the event was themed after the movie—of course—with teaching assistants dressing up as Jedi Knights and professor Michael Tolley donning a Star Wars rebel helmet. A total of 45 teams and 165 students vied for the big win.
Neurosurgeons at UC San Diego Health have initiated a landmark, multi-center study to evaluate how the treatment of brain tumors using the NeuroBlate system, a minimally invasive, FDA-approved laser device, impacts the quality of life of patients.
In the first clinical trial of its type, researchers at University of California, San Diego School of Medicine and the Alzheimer’s Disease Cooperative Study (ADCS), in collaboration with AC Immune, a biotechnology company based in Switzerland, will test the safety and tolerability of an immunotherapy vaccine that targets Alzheimer’s disease-like characteristics in adults with Down syndrome.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
